System Formulary Addition
Buprenorphine Buccal Film
Situation
The formulary review of buprenorphine buccal film was approved at the September 2020 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was requested for formulary addition: buprenorphine buccal film (Belbuca)
Assessment/Recommendation
Go-Live: Tuesday, December 15, 2020
System P&T voted to include the following products on the UNC Health Medication Formulary:
Use of buprenorphine buccal film is restricted to patients continuing home therapy.
Note: Stock of these formulary products may vary at individual entities